PCN105 PATIENT PREFERENCE-BASED UTILITY WEIGHTS FROM THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL (FACT-G) IN WOMEN WITH HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER RECEIVING LETROZOLE PLUS LAPATINIB OR LETROZOLE ALONE
May 1, 2010, 00:00
10.1016/S1098-3015(10)72194-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)72194-X/fulltext
Title :
PCN105 PATIENT PREFERENCE-BASED UTILITY WEIGHTS FROM THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL (FACT-G) IN WOMEN WITH HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER RECEIVING LETROZOLE PLUS LAPATINIB OR LETROZOLE ALONE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72194-X&doi=10.1016/S1098-3015(10)72194-X
First page :
Section Title :
Open access? :
No
Section Order :
778